The new paradigm in insulin management has arrived - Once-weekly Awiqli®

Much has changed since Canada's discovery of insulin 100 years ago. Over the past century, insulin has played an important life-saving role for people living with diabetes. Current insulins require one or even multiple injections on a daily basis. However, recent advancements in insulin analogues have greatly extended the duration of action to now permit weekly injections.

Learn about the latest innovations in insulin therapy, the clinical and workplace value of once-weekly insulin management, and its potentially positive impacts to alleviate the burden of diabetes and improve care/outcomes.

Join us for an exclusive webinar presentation that delves into the exciting advancements in insulin therapy. In this session, you'll gain valuable insights into the future of diabetes management, with a focus on Awiqli® - Canada’s first once-weekly insulin.

Join this webinar to learn more about:

  • The evolution of insulin management
  • Potential workplace benefits of once-weekly insulin administration
  • How weekly basal insulins address a major unmet need for plan members living with diabetes by reducing injection burden, increasing treatment satisfaction, and improving glycemic control.

Don't miss this opportunity to elevate your understanding of insulin therapy and discover how once-weekly Awiqli® is transforming the way we approach diabetes care. Register now to secure your place today!

Sponsored by: